Changes in Exercise Capacity and Cardiac Performance in a Series of Patients with Eisenmenger’s Syndrome Transitioned from Selective to Dual Endothelin Receptor Antagonist - 08/11/12
, Anna Tyrka, MD a, Tomasz Miszalski-Jamka, PhD b, Tomasz Mikołajczyk, PhD c, Marcin Waligóra, MD a, Tomasz Guzik, PhD c, Piotr Podolec, PhD a
Corresponding author at: Department of Cardiac and Vascular Diseases, John Paul II Hospital, Krakow, Poland, ul. Pradnicka 80, 31-202 Krakow, Poland. Tel.: +48 12 614 33 99; fax: +48 12 614 34 88.Résumé |
Background |
Differences in clinical effects between selective and dual endothelin (ET) receptor antagonists (ERA) in patients with pulmonary arterial hypertension (PAH) are currently unknown. We aimed to assess prospectively how transition from selective (sitaxsentan) to dual (bosentan) ERA affected exercise capacity and cardiocirculatory performance in patients with Eisenmenger’s syndrome.
Methods |
A series of seven stable patients with Eisenmenger’s syndrome aged 40.0 (30.0–56.0) years old treated with sitaxsentan were assessed before and three months after transition to bosentan. Six minute walk test and magnetic resonance to assess LV and RV mass, volume and ejection fraction, and pulmonary flow, and laboratory tests were performed.
Results |
We observed an increase in LV mass [96.5 (66.0–116.0) vs. 123.0 (93.0–146.0)g; p=0.03], LV ejection fraction [55.0 (44.0–63.0) vs. 65.0 (58.0–70.0)%; p=0.02)], and pulmonary flow [64 (53.0–71.0) vs. 69.0 (55.0–84.0)ml/beat; p=0.046]. This was accompanied by an increase of oxygen saturation, elongation of 6MWD [435.0 (378.0–482.3) vs. 474 (405.0–534.7); p=0.02], decrease of NTproBNP level and increase of ET-1 level.
Conclusions |
Three month follow-up of stable patients with Eisenmenger’s syndrome transitioned from sitaxsentan to bosentan revealed improvement of exercise capacity despite significant elevation of ET-1 level. Concurrent increase of LV ejection fraction and pulmonary flow might have contributed to these favourable effects.
Le texte complet de cet article est disponible en PDF.Keywords : Pulmonary hypertension, Endothelin, Magnetic resonance imaging, Exercise capacity, 6 Minute walk test, Bosentan, Sitaxsentan, Eisenmenger’s syndrome
Plan
Vol 21 - N° 11
P. 671-678 - novembre 2012 Retour au numéro
Article précédent
- Congenital Complete Heart Block: Single Tertiary Centre Experience
- Jennifer Yan, Suraj K. Varma, Atul Malhotra, Samuel Menahem
- Effect of Preoperational Mechanical Ventilation on Short-Term Postoperative Outcomes in Patients with Severe Tetralogy of Fallot
- Ming-Feng Dong, Zeng-Shan Ma, Jian-Tang Wang, Shou-Dong Chai, Pei-Zhe Tang, Le-Xin Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?